FTC/CVS
This article was originally published in The Tan Sheet
Executive Summary
CVS agrees to pay a $600,000 civil penalty for violating a 1997 consent agreement regarding the divestiture of 113 Revco pharmacies to Eckerd. Because CVS removed the computerized pharmacy recordkeeping systems from the Revco pharmacies, consumers were denied the benefits of full competition, the Federal Trade Commission alleges in its complaint. CVS agreed to the divestiture in May 1997 ("The Tan Sheet" June 2, 1997, p. 16)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning